Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,950.00
-70.00 (-1.39%)
At close: Jun 19, 2026
Market Cap44.71B -33.4%
Revenue (ttm)78.58B +5.4%
Net Income518.17M -81.0%
EPS32.77 -89.6%
Shares Out 9.03M
PE Ratio151.07
Forward PEn/a
Dividend95.47 (1.93%)
Ex-Dividend DateDec 29, 2025
Volume64,175
Open5,020.00
Previous Close5,020.00
Day's Range4,850.00 - 5,040.00
52-Week Range4,780.00 - 8,268.31
Beta0.60
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About Seoulin Bioscience

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1984
Employees 104
Stock Exchange KOSDAQ
Ticker Symbol 038070
Full Company Profile

Financial Performance

In 2025, Seoulin Bioscience's revenue was 77.09 billion, an increase of 2.23% compared to the previous year's 75.41 billion. Earnings were 731.98 million, a decrease of -74.88%.

Financial Statements